Home › Mga Sakit sa Baga › District of Columbia
Pag-aaral pangklinika para sa Mga Sakit sa Baga sa District of Columbia
6 pag-aaral para sa Mga Sakit sa Baga ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Georgetown University Medical Center, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07013474A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- Georgetown University Medical Center, Washington D.C.
- Emerson Clinical Research Institute, Washington D.C.
Nagre-recruitPhase 3
Edad 12 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06679140A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
- Site 1001, Washington D.C.
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 17, 2026 · NCT07407933A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Sibley Memorial Hospital, Washington D.C.
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 8, 2026 · NCT06119581Cooperative Assessment of Late Effects for SCD Curative Therapies
- Children's National Medical Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 4 hanggang 65 · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05153967Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.